Jump to content

Mannose

From Wikipedia, the free encyclopedia
(Redirected from D-Mannose)
Mannose

D-Mannopyranose

Fischer projections
Names
IUPAC name
Mannose
Systematic IUPAC name
(3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
Identifiers
ChEMBL
ChemSpider
KEGG
MeSH Mannose
UNII
Properties
C6H12O6
Molar mass 180.156 g·mol−1
Appearance white solid
Density 1.554 g/cm3
Melting point 132 °C (270 °F; 405 K)
-102.90·10−6 cm3/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Mannose is a sugar with the formula HOCH2(CHOH)4CHO. It is one of the monomers of the aldohexose series of carbohydrates. It is a C-2 epimer of glucose. Mannose is important in human metabolism, especially in the glycosylation of certain proteins. Several congenital disorders of glycosylation are associated with mutations in enzymes involved in mannose metabolism.[1]

Mannose is not an essential nutrient; it can be produced in the human body from glucose, or converted into glucose. Mannose provides 2–5 kcal/g. It is partially excreted in the urine.

Etymology

[edit]

The root of both "mannose" and "mannitol" is manna, which the Bible describes as the food supplied to the Israelites during their journey in the region of Sinai. Several trees and shrubs can produce a substance called manna, such as the "manna tree" (Fraxinus ornus) from whose secretions mannitol was originally isolated.[citation needed]

Structure

[edit]

Mannose commonly exists as two different-sized rings, the pyranose (six-membered) form and the furanose (five-membered) form. Each ring closure can have either an alpha or beta configuration at the anomeric position. The chemical rapidly undergoes isomerization among these four forms.[citation needed]

D-Mannose isomers (Haworth projections)
Percent composition[2]

α-D-Mannofuranose
0.6%
β-D-Mannofuranose
0.2%

α-D-Mannopyranose
63.7%
β-D-Mannopyranose
35.5%

Metabolism

[edit]
Mannose metabolism in human beings

While much of the mannose used in glycosylation is believed to be derived from glucose, in cultured hepatoma cells (cancerous cells from the liver), most of the mannose for glycoprotein biosynthesis comes from extracellular mannose, not glucose.[3] Many of the glycoproteins produced in the liver are secreted into the bloodstream, so dietary mannose is distributed throughout the body.[4]

Mannose is present in numerous glycoconjugates including N-linked glycosylation of proteins. C-Mannosylation is also abundant and can be found in collagen-like regions.[citation needed]

The digestion of many polysaccharides and glycoproteins yields mannose, which is phosphorylated by hexokinase to generate mannose-6-phosphate. Mannose-6-phosphate is converted to fructose-6-phosphate, by the enzyme phosphomannose isomerase, and then enters the glycolytic pathway or is converted to glucose-6-phosphate by the gluconeogenic pathway of hepatocytes.[citation needed]

Mannose is a dominant monosaccharide in N-linked glycosylation, which is a post-translational modification of proteins. It is initiated by the en bloc transfer on Glc3Man9GlcNAc2 to nascent glycoproteins in the endoplasmic reticulum (ER) in a co-translational manner as the protein entered through the transport system. Glucose is hydrolyzed on fully folded protein and the mannose moieties are hydrolyzed by ER and Golgi-resident mannosidases. Typically, mature human glycoproteins only contain three mannose residues buried under sequential modification by GlcNAc, galactose, and sialic acid. This is important, as the innate immune system in mammals is geared to recognise exposed mannose residues. This activity is due to the prevalence of mannose residues, in the form of mannans, on the surfaces of yeasts. The human immunodeficiency virus displays considerable amount of mannose residues due to the tight clustering of glycans in its viral spike.[5][6] These mannose residues are the target for broadly neutralizing antibodies.[7]

Biotechnology

[edit]

Recombinant proteins produced in yeast may be subject to mannose addition in patterns different from those used by mammalian cells.[8] This difference in recombinant proteins from those normally produced in mammalian organisms may influence the effectiveness of vaccines.[citation needed]

Formation

[edit]

Mannose can be formed by the oxidation of mannitol.[citation needed]

It can also be formed from glucose in the Lobry de Bruyn–van Ekenstein transformation.[citation needed]

Uses

[edit]

Mannose (D-mannose) is used as a dietary supplement to prevent recurrent urinary tract infections (UTIs).[9][10] As of 2022, one review found that taking mannose was as effective as antibiotics to prevent UTIs,[9] while another review found that clinical trial quality was too low to allow any conclusion about using D‐mannose to prevent or treat UTIs.[10] In 2024, a randomized clinical trial among 598 women with recurrent UTI recruited from primary care settings found the proportion experiencing a medically attended UTI was 51.0% in those taking daily D-mannose over 6 months and 55.7% in those taking placebo, concluding that D-mannose should not be recommended to prevent future episodes of medically attended UTI in women with recurrent UTI in primary care.[11]

Configuration

[edit]

Mannose differs from glucose by inversion of the C-2 chiral center. Mannose displays a pucker in the solution ring form. This simple change leads to the drastically different biochemistry of the two hexoses. This change has the same effect on the other aldohexoses, as well.[citation needed]

Mannose PTS permease

[edit]
See also: PEP group translocation
Mannose XYZ permease complex: entry of PEP which donates a high energy phosphate that gets passed through the transporter system and eventually assist in the entry of mannose (in this example otherwise it would any hexose sugar) and results in the formation of mannose-6-phosphate.
Video illustration of the MANXYZ sugar transporter complex transferring the high energy phosphate for PEP to the other subunits of the complex

The PEP-dependent sugar transporting phosphotransferase system transports and simultaneously phosphorylates its sugar substrates. Mannose XYZ permease is a member of the family, with this distinct method being used by bacteria for sugar uptake particularly exogenous hexoses in the case of mannose XYZ to release the phosphate esters into the cell cytoplasm in preparation for metabolism primarily through the route of glycolysis.[12] The MANXYZ transporter complex is also involved in infection of E. coli by bacteriophage lambda, with subunit ManY and ManZ being sufficient for proper lambda phage infection.[13] MANXYZ possesses four domains in three polypeptide chains; ManX, ManY, and ManZ. The ManX subunit forms a homodimer that is localized to the cytoplasmic side of the membrane. ManX contains two domains IIA and IIB linked by a hinge peptide with each domain containing a phosphorylation site and phosphoryl transfer occurs between both subunits.[14] ManX can be membrane bound or not.[13] The ManY and ManNZ subunits are hydrophobic integral membrane proteins with six and one transmembrane alpha helical spanner(s).[15][16][17] The phosphoryl group of PEP is transferred to the imported sugar via Enzyme 1, histidine protein phosphate carrier, and then to the ManX, ManY, and ManZ subunits of the ManXYZ transportation complex, which phosphorylates the entering hexose sugar, creating a hexose-6-phosphate.[citation needed]

See also

[edit]

References

[edit]
  1. ^ Freeze, H. H.; Sharma, V. (2010). "Metabolic manipulation of glycosylation disorders in humans and animal models". Seminars in Cell & Developmental Biology. 21 (6): 655–662. doi:10.1016/j.semcdb.2010.03.011. PMC 2917643. PMID 20363348.
  2. ^ Witczak, Zbigniew J. (2001). "Monosaccharides. Properties". In Fraser-Reid, Bertram O.; Tatsuta, Kuniaki; Thiem, Joachim (eds.). Glycoscience. Chemistry and Chemical Biology I–III. Springer. p. 887. doi:10.1007/978-3-642-56874-9. ISBN 978-3-642-56874-9.
  3. ^ Alton, G.; Hasilik, M.; Niehues, R.; Panneerselvam, K.; Etchison, J. R.; Fana, F.; Freeze, H. H. (1998). "Direct utilization of mannose for mammalian glycoprotein biosynthesis". Glycobiology. 8 (3): 285–295. doi:10.1093/glycob/8.3.285. PMID 9451038.
  4. ^ Davis, J. A.; Freeze, H. H. (2001). "Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse". Biochimica et Biophysica Acta (BBA) - General Subjects. 1528 (2–3): 116–126. doi:10.1016/S0304-4165(01)00183-0. PMID 11687298.
  5. ^ Pritchard, Laura K.; Spencer, Daniel I. R.; Royle, Louise; Bonomelli, Camille; Seabright, Gemma E.; Behrens, Anna-Janina; Kulp, Daniel W.; Menis, Sergey; Krumm, Stefanie A. (2015-06-24). "Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies". Nature Communications. 6: 7479. Bibcode:2015NatCo...6.7479P. doi:10.1038/ncomms8479. PMC 4500839. PMID 26105115.
  6. ^ Pritchard, Laura K.; Vasiljevic, Snezana; Ozorowski, Gabriel; Seabright, Gemma E.; Cupo, Albert; Ringe, Rajesh; Kim, Helen J.; Sanders, Rogier W.; Doores, Katie J. (2015-06-16). "Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers". Cell Reports. 11 (10): 1604–1613. doi:10.1016/j.celrep.2015.05.017. ISSN 2211-1247. PMC 4555872. PMID 26051934.
  7. ^ Crispin, Max; Doores, Katie J (2015-04-01). "Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design". Current Opinion in Virology. Viral pathogenesis • Preventive and therapeutic vaccines. 11: 63–69. doi:10.1016/j.coviro.2015.02.002. PMC 4827424. PMID 25747313.
  8. ^ Vlahopoulos, S.; Gritzapis, A. D.; Perez, S. A.; Cacoullos, N.; Papamichail, M.; Baxevanis, C. N. (2009). "Mannose addition by yeast Pichia pastoris on recombinant HER-2 protein inhibits recognition by the monoclonal antibody herceptin". Vaccine. 27 (34): 4704–4708. doi:10.1016/j.vaccine.2009.05.063. PMID 19520203.
  9. ^ a b Lenger, Stacy M.; Bradley, Megan S.; Thomas, Debbie A.; Bertolet, Marnie H.; Lowder, Jerry L.; Sutcliffe, Siobhan (1 August 2020). "D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis". American Journal of Obstetrics and Gynecology. 223 (2): 265.e1–265.e13. doi:10.1016/j.ajog.2020.05.048. PMC 7395894. PMID 32497610.
  10. ^ a b Cooper, Tess E; Teng, Claris; Howell, Martin; Teixeira-Pinto, Armando; Jaure, Allison; Wong, Germaine (30 August 2022). "D-mannose for preventing and treating urinary tract infections". Cochrane Database of Systematic Reviews. 2022 (8): CD013608. doi:10.1002/14651858.CD013608.pub2. PMC 9427198. PMID 36041061.
  11. ^ Gail Hayward; Sam Mort; Alastair D. Hay; et al. (April 8, 2024). "d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women | A Randomized Clinical Trial". JAMA Intern. Med. 184 (6): 619–628. doi:10.1001/jamainternmed.2024.0264. PMC 11002776. PMID 38587819.{{cite journal}}: CS1 maint: date and year (link)
  12. ^ Postma, P. W.; Lengeler, J. W.; Jacobson, G. R. (1993). "Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria". Microbiological Reviews. 57 (3): 543–594. doi:10.1128/MMBR.57.3.543-594.1993. PMC 372926. PMID 8246840.
  13. ^ a b Erni, B.; Zanolari, B. (1985). "The mannose-permease of the bacterial phosphotransferase system. Gene cloning and purification of the enzyme IIMan/IIIMan complex of Escherichia coli". The Journal of Biological Chemistry. 260 (29): 15495–15503. doi:10.1016/S0021-9258(17)36282-8. PMID 2999119.
  14. ^ Erni, B.; Zanolari, B.; Graff, P.; Kocher, H. P. (1989). "Mannose permease of Escherichia coli. Domain structure and function of the phosphorylating subunit". The Journal of Biological Chemistry. 264 (31): 18733–18741. doi:10.1016/S0021-9258(18)51529-5. PMID 2681202.
  15. ^ Huber, F.; Erni, B. (1996). "Membrane topology of the mannose transporter of Escherichia coli K12". European Journal of Biochemistry. 239 (3): 810–817. doi:10.1111/j.1432-1033.1996.0810u.x. PMID 8774730.
  16. ^ Liu, Xueli; Zeng, Jianwei; Huang, Kai; Wang, Jiawei (2019-06-17). "Structure of the mannose transporter of the bacterial phosphotransferase system". Cell Research. 29 (8): 680–682. doi:10.1038/s41422-019-0194-z. ISSN 1748-7838. PMC 6796895. PMID 31209249.
  17. ^ Huang, Kai; Zeng, Jianwei; Liu, Xueli; Jiang, Tianyu; Wang, Jiawei (2021-04-06). "Structure of the mannose phosphotransferase system (man-PTS) complexed with microcin E492, a pore-forming bacteriocin". Cell Discovery. 7 (1): 20. doi:10.1038/s41421-021-00253-6. ISSN 2056-5968. PMC 8021565. PMID 33820910.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mannose&oldid=1257630479"